NVP-AUY922:: A novel small molecule HSP90 inhibitor with potent in vivo antitumor efficacy

被引：0
|
作者：
Jensen, Michael Rugaard [1 ]
Schoepfer, Joseph [1 ]
Radimersky, Thomas [1 ]
Massey, Andrew [2 ]
Brueggen, Josef [1 ]
Schweitzer, Alain [3 ]
Pfaar, Ulrike [3 ]
Ruetz, Stephan [1 ]
Guy, Chantal [4 ]
Buckler, Alan [4 ]
Schnell, Christian [1 ]
Cozens, Robert [1 ]
Brough, Paul [2 ]
Drysdale, Martin [2 ]
Quadt, Cornelia [3 ]
Garcia-Echeverria, Carlos [1 ]
Chene, Patrick [1 ]
机构：
[1] Novartis Inst BioMed Res, Basel, Switzerland
[2] Vernalis Ltd, Cambridge, England
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Inst BioMed Res, Cambridge, England
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3521S / 3521S
页数：1
相关论文
共 50 条
  • [21] Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
    Bao, Xiao-Hong
    Takaoka, Munenori
    Hao, Hui-Fang
    Fukazawa, Takuya
    Yamatsuji, Tomoki
    Sakurama, Kazufumi
    Takigawa, Nagio
    Nakajima, Motowo
    Fujiwara, Toshiyoshi
    Naomoto, Yoshio
    ONCOLOGY REPORTS, 2013, 29 (01) : 45 - 50
  • [22] HSP90 inhibitor NVP-AUY922 exhibits the potent antiproliferative effect in gastrointestinal cancer cells with a lack of PTEN expression
    Takaoka, Munenori
    Bao, Xiaohong
    Hao, Huifang
    Fukazawa, Takuya
    Yamatsuji, Tomoki
    Tomono, Yasuko
    Sakurama, Kazufumi
    Naomoto, Yoshio
    CANCER RESEARCH, 2012, 72
  • [23] Signaling profile and anti-tumor activity of the novel HSP90 inhibitor NVP-AUY922 in multiple myeloma
    Stuehmer, Thorsten
    Zoellinger, Angela
    Siegmund, Daniela
    Chatterjee, Manik
    Grella, Evelyn
    Knop, Stefan
    Kortuem, Martin
    Unzicker, Christian
    Jensen, Michael R.
    Quadt, Cornelia
    Chene, Patrick
    Schoepfer, Joseph
    Garcia-Echeverria, Carlos
    Einsele, Herrmann
    Wajant, Harald
    Bargou, Ralf C.
    BLOOD, 2007, 110 (11) : 270B - 271B
  • [24] Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer
    Ueno, Tsuyoshi
    Tsukuda, Kazunori
    Toyooka, Shinichi
    Ando, Midori
    Takaoka, Munenori
    Soh, Junichi
    Asano, Hiroaki
    Maki, Yuho
    Muraoka, Takayuki
    Tanaka, Norimitsu
    Shien, Kazuhiko
    Furukawa, Masashi
    Yamatsuji, Tomoki
    Kiura, Katsuyuki
    Naomoto, Yoshio
    Miyoshi, Shinichiro
    LUNG CANCER, 2012, 76 (01) : 26 - 31
  • [25] Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922
    Bergstrom, Mats
    Monazzam, Azita
    Razifar, Pasha
    Ide, Susan
    Josephsson, Raymond
    Langstrom, Bengt
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (07) : 1204 - 1210
  • [26] Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia
    Djuzenova, Cholpon S.
    Blassl, Christina
    Roloff, Konstanze
    Kuger, Sebastian
    Katzer, Astrid
    Niewidok, Natalia
    Guenther, Nadine
    Polat, Buelent
    Sukhorukov, Vladimir L.
    Flentje, Michael
    CANCER BIOLOGY & THERAPY, 2012, 13 (06) : 425 - 434
  • [27] NVP-AUY922, a novel diarylisoxazole resorcinol HSP90 inhibitor, potently inhibits growth and metastasis of human tumor xenografts
    Eccles, Suzanne A.
    Sharp, Swee Y.
    Raynaud, Florence I.
    Valenti, Melanie
    Patterson, Lisa
    Gowan, Sharon
    Boxall, Kathy
    Aherne, Wynne
    Rowlands, Martin
    Hayes, Angela
    Martins, Vanessa
    Urban, Federique
    Prodromou, Chrisostomos
    Pearl, Laurence
    James, Karen
    Matthews, Thomas P.
    Cheung, Kwai-Ming
    Kalusa, Andrew
    Jones, Keith
    McDonald, Edward
    Brough, Paul A.
    Massey, Andrew
    Dymock, Brian
    Drysdale, Martin
    Workman, Paul
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3522S - 3523S
  • [28] Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma
    Kaiser, Martin
    Lamottke, Britta
    Mieth, Maren
    Jensen, Michael R.
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    Atadja, Peter
    Heider, Ulrike
    von Metzler, Ivana
    Tuerkmen, Seval
    Sezer, Orhan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (04) : 337 - 344
  • [29] Pharmakokinetic/phamacodynamic relationship in human xenograft models and PBMC's treated with the Hsp90 inhibitor NVP-AUY922
    Jensen, M. R.
    Ide, S.
    Brueggen, J.
    Schoepfer, J.
    Motwani, M.
    Wang, X.
    Radimerski, T.
    Quadt, C.
    Garcia-Echeverria, C.
    Chene, P.
    EJC SUPPLEMENTS, 2008, 6 (12): : 50 - 50
  • [30] HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice
    Chittoor-Vinod, Vinita G.
    Bazick, Hannah
    Todd, Adrian G.
    Falk, Darin
    Morelli, Kathryn H.
    Burgess, Robert W.
    Foster, Thomas C.
    Notterpek, Lucia
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (06): : 2890 - 2902
12345